Haller DG - Search Results

1

Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.

Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB 3rd, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA. Lenz HJ, et al. Among authors: haller dg. Cancer. 2007 Jan 1;109(1):33-40. doi: 10.1002/cncr.22329. Cancer. 2007. PMID: 17133415 Free article.

2

A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.

Ajani JA, Kelsen DP, Haller D, Hargraves K, Healey D. Ajani JA, et al. Cancer J. 2000 Mar-Apr;6(2):78-81. Cancer J. 2000. PMID: 11069223 Clinical Trial.

3

A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors.

Sun W, Stevenson JP, Gallagher M, Giantonio B, Algazy K, Haller D, Vaughn D, Raskay BJ, O'Dwyer PJ. Sun W, et al. Cancer. 2001 Jul 15;92(2):414-9. doi: 10.1002/1097-0142(20010715)92:2<414::aid-cncr1337>3.0.co;2-w. Cancer. 2001. PMID: 11466697 Clinical Trial.

4

Docetaxel in advanced gastric cancer.

Haller DG, Misset JL. Haller DG, et al. Anticancer Drugs. 2002 Jun;13(5):451-60. doi: 10.1097/00001813-200206000-00003. Anticancer Drugs. 2002. PMID: 12045456 Review.

5

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB 3rd. Berlin JD, et al. Among authors: haller dg. J Clin Oncol. 2002 Aug 1;20(15):3270-5. doi: 10.1200/JCO.2002.11.149. J Clin Oncol. 2002. PMID: 12149301 Clinical Trial.

6

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. McCollum AD, et al. Among authors: haller dg. J Natl Cancer Inst. 2002 Aug 7;94(15):1160-7. doi: 10.1093/jnci/94.15.1160. J Natl Cancer Inst. 2002. PMID: 12165641 Clinical Trial.

7

Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.

Gunderson LL, Sargent DJ, Tepper JE, O'Connell MJ, Allmer C, Smalley SR, Martenson JA, Haller DG, Mayer RJ, Rich TA, Ajani JA, Macdonald JS, Goldberg RM. Gunderson LL, et al. Among authors: haller dg. Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):386-96. doi: 10.1016/s0360-3016(02)02945-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12243812 Clinical Trial.

8

Impact of diabetes mellitus on outcomes in patients with colon cancer.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Meyerhardt JA, et al. Among authors: haller dg. J Clin Oncol. 2003 Feb 1;21(3):433-40. doi: 10.1200/JCO.2003.07.125. J Clin Oncol. 2003. PMID: 12560431 Clinical Trial.

9

Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.

Flaherty KT, Stevenson JP, Gallagher M, Giantonio B, Algazy KM, Sun W, Haller DG, O'Dwyer PJ. Flaherty KT, et al. Among authors: haller dg. Cancer. 2003 Apr 15;97(8):1985-90. doi: 10.1002/cncr.11273. Cancer. 2003. PMID: 12673728 Free article. Clinical Trial.

10

Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, Fuchs CS. Meyerhardt JA, et al. Among authors: haller dg. Cancer. 2003 Aug 1;98(3):484-95. doi: 10.1002/cncr.11544. Cancer. 2003. PMID: 12879464 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page